Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The ATTAIN-2 results reinforce the potential for orforglipron, as a once-daily oral, to deliver meaningful weight loss and A1C reduction, consistent with similar landmark trials for injectable GLP-1s, Custer added
This is not a timing question
Goldstein AL, Hannappel E, Sosne G, Kleinman HK
Patients who remained on GLP-1 therapy for the full three-year period had substantially fewer major adverse cardiovascular events and deaths than those treated with other medications
Treatment and support are available
Tirzepatide Mechanisms Tirzepatides dual-action mechanism offers a broader approach: GLP-1 and GIP Activation : By targeting both GLP-1 and GIP receptors, Tirzepatide enhances insulin secretion and significantly reduces appetite more than Semaglutide alone
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
